Apyx Medical Corporation
APYXNASDAQHealthcare● Active
$4.77
+$0.30(+6.71%)
Market Cap$199738746
P/E Ratio—
52W High$4.97
52W Low$1.553
Apyx Medical Corporation (APYX) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · APYX · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $52.84M | $48.10M | $52.35M | $44.51M | $48.52M |
| Cost of Revenue | $33.81M | $18.74M | $18.59M | $15.38M | $14.92M |
| Gross Profit | $19.03M | $29.36M | $33.76M | $29.13M | $33.60M |
| Gross Margin %(computed) | 36.02% | 61.04% | 64.49% | 65.45% | 69.26% |
| Operating Expenses | |||||
| R&D Expenses | $3.37M | $5.08M | $4.84M | $4.54M | $4.32M |
| G&A Expenses | $36.12M | $43.13M | $48.87M | $48.15M | $43.73M |
| Total Operating Expenses | $25.48M | $48.20M | $51.02M | $52.69M | $48.05M |
| Operating Income | ($6.45M) | ($18.84M) | ($17.26M) | ($23.56M) | ($14.45M) |
| Operating Margin %(computed) | -12.20% | -39.18% | -32.97% | -52.94% | -29.78% |
| Interest Income | $1.11M | $1.61M | $0.92M | $0.16M | $0.01M |
| Interest Expense | $5.59M | $5.91M | $2.48M | $0.01M | $0.01M |
| Income Before Tax | ($10.84M) | ($23.31M) | ($21.28M) | ($22.91M) | ($14.82M) |
| Income Tax Expense | $0.27M | $0.25M | ($2.43M) | $0.37M | $0.38M |
| Net Income | ($11.21M) | ($23.46M) | ($18.71M) | ($23.18M) | ($15.17M) |
| Net Margin %(computed) | -21.22% | -48.78% | -35.75% | -52.09% | -31.27% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.27 | $-0.66 | $-0.54 | $-0.67 | $-0.44 |
| Wtd Avg Shares | 42.16M | 35.54M | 34.62M | 34.52M | 34.33M |
| EBITDA | ($5.79M) | ($16.80M) | ($18.11M) | ($22.01M) | ($13.91M) |
| EBITDA Margin %(computed) | -10.96% | -34.93% | -34.60% | -49.44% | -28.66% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · M
Explore more Apyx Medical Corporation data
About Apyx Medical Corporation (APYX) Income Statement
Apyx Medical Corporation (APYX) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, APYX reported revenue of $0.05B, gross profit of $0.02B (gross margin 36.02%), and net income of ($0.01B) — a net profit margin of -21.22%.
Frequently asked questions
APYX · 4 questionsApyx Medical Corporation (APYX) reported revenue of $0.05B for 2025, up 9.9% year-over-year.
APYX revenueAPYX salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08